Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Similar articles for PubMed (Select 21127096)

1.

Development of a computerised alert system, ADEAS, to identify patients at risk for an adverse drug event.

Rommers MK, Zegers MH, De Clercq PA, Bouvy ML, de Meijer PH, Teepe-Twiss IM, Guchelaar HJ.

Qual Saf Health Care. 2010 Dec;19(6):e35. doi: 10.1136/qshc.2009.033704.

PMID:
21127096
2.

Reduction in chemotherapy order errors with computerised physician order entry and clinical decision support systems.

Aziz MT, Ur-Rehman T, Qureshi S, Bukhari NI.

HIM J. 2015 Jun 26. [Epub ahead of print] No abstract available.

PMID:
26113438
3.

Prevent adverse drug events from topical medications.

Cohen H.

Nursing. 2013 Jul;43(7):68-9. doi: 10.1097/01.NURSE.0000429812.64600.bf. No abstract available.

PMID:
23778220
4.

Evaluation of rule effectiveness and positive predictive value of clinical rules in a Dutch clinical decision support system in daily hospital pharmacy practice.

Rommers MK, Zwaveling J, Guchelaar HJ, Teepe-Twiss IM.

Artif Intell Med. 2013 Sep;59(1):15-21. doi: 10.1016/j.artmed.2013.04.001. Epub 2013 May 7.

PMID:
23664455
5.

Adverse drug event prevention in neonatal care: a rule-based approach.

Lazou K, Farini M, Koutkias V, Drossou V, Maglaveras N, Bassiliades N.

Stud Health Technol Inform. 2013;186:170-4.

PMID:
23542991
6.

[Prediction and prevention of severe adverse effects and hazardous interactions of drugs].

Neuvonen PJ.

Duodecim. 2013;129(1):22-30. Review. Finnish.

PMID:
23431879
7.

Labeling an adverse drug event "preventable".

Blumenthal D.

Virtual Mentor. 2011 Sep 1;13(9):601-8. doi: 10.1001/virtualmentor.2011.13.9.ccas2-1109. No abstract available.

8.

Characteristics of patients at risk for adverse drug events: designing for patient safety and decision support.

Borycki E, Barnett J, Walisser S, Bellwood P, Clarke M, Greig D.

Stud Health Technol Inform. 2012;180:290-4.

PMID:
22874198
9.

Knowledge engineering for adverse drug event prevention: on the design and development of a uniform, contextualized and sustainable knowledge-based framework.

Koutkias V, Kilintzis V, Stalidis G, Lazou K, Ni├Ęs J, Durand-Texte L, McNair P, Beuscart R, Maglaveras N.

J Biomed Inform. 2012 Jun;45(3):495-506. doi: 10.1016/j.jbi.2012.01.007. Epub 2012 Feb 2.

10.

Validation of completeness, correctness, relevance and understandability of the PSIP CDSS for medication safety.

Ammenwerth E, Hackl WO, Massari P, Darmoni S.

Stud Health Technol Inform. 2011;166:254-9.

PMID:
21685631
11.

Assessment of three systems to empower the patient and decrease the risk of adverse drug events.

Lawton K, Skjoet P.

Stud Health Technol Inform. 2011;166:246-53.

PMID:
21685630
12.

Three different cases of exploiting decision support services for adverse drug event prevention.

Bernonille S, Nies J, Pedersen HG, Guillot B, Maazi M, Berg AL, Sarfati JC, Koutkias V.

Stud Health Technol Inform. 2011;166:180-8.

PMID:
21685623
13.

Towards a standardised representation of a knowledge base for adverse drug event prevention.

Koutkias V, Lazou K, de Clercq P, Maglaveras N.

Stud Health Technol Inform. 2011;166:139-47.

PMID:
21685619
14.

Information contextualization in decision support modules for adverse drug event prevention.

Nies J, Koutkias V, Kilintzis V, Guillot B, Maglaveras N, Pedersen HG, Berg AL, Skjoet P.

Stud Health Technol Inform. 2011;166:95-104.

PMID:
21685615
15.

Drug knowledge expressed as computable semantic triples.

Elkin PL, Carter JS, Nabar M, Tuttle M, Lincoln M, Brown SH.

Stud Health Technol Inform. 2011;166:38-47.

PMID:
21685609
16.

PSIP: an overview of the results and clinical implications.

Beuscart R.

Stud Health Technol Inform. 2011;166:3-12.

PMID:
21685604
17.

Consensus building for development of outpatient adverse drug event triggers.

Mull HJ, Nebeker JR, Shimada SL, Kaafarani HM, Rivard PE, Rosen AK.

J Patient Saf. 2011 Jun;7(2):66-71. doi: 10.1097/PTS.0b013e31820c98ba.

PMID:
21587117
18.

A computerized adverse drug event alerting system using clinical rules: a retrospective and prospective comparison with conventional medication surveillance in the Netherlands.

Rommers MK, Teepe-Twiss IM, Guchelaar HJ.

Drug Saf. 2011 Mar 1;34(3):233-42. doi: 10.2165/11536500-000000000-00000.

PMID:
21332247
19.

Impact of health information technology on detection of potential adverse drug events at the ordering stage.

Roberts LL, Ward MM, Brokel JM, Wakefield DS, Crandall DK, Conlon P.

Am J Health Syst Pharm. 2010 Nov 1;67(21):1838-46. doi: 10.2146/ajhp090637.

PMID:
20966148
20.

Grading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankings.

Smithburger PL, Kane-Gill SL, Benedict NJ, Falcione BA, Seybert AL.

Ann Pharmacother. 2010 Nov;44(11):1718-24. doi: 10.1345/aph.1P377. Epub 2010 Oct 19.

PMID:
20959499
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk